The global demand for Lipid Disorder Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Lipid disorder is a metabolic condition that affects blood lipid levels. The condition causes high blood levels of low-density lipoprotein (LDL) cholesterol, and fats called triglycerides or both. High levels of LDL cholesterol and triglycerides increase the risk of developing heart disease. These levels can be reduced by some primary options such as eating less fat, exercising regularly and losing weight if one is obese. However, these options are not always effective. In such cases medication is prescribed to control the level, medications, such as statins, are effective in lowering cholesterol levels for many patients. Other medications, including bile acid sequestrants, fibric acid derivatives, cholesterol absorption inhibitors, and niacin can also help control lipid levels.
The rising global burden and growing geriatric population will be driving the growth of the market. The increasing prevalence of lipid disorders has become a global public health problem. In 2017, 4.32 million deaths were estimated owing to high low-density lipoprotein cholesterol globally. Globally geriatric population who are more prevelant to lipipd disorder is growing considerably faster than the population as a whole, and it is expected to continue growing more rapidly at least till 2050. Apart from ageing, gender, genetic susceptibility, chronic diseases, medications, certain lifestyles including excessive intake of foods high in saturated or trans fats, physical inactivity, obesity and smoking also contribute to blood lipid disorders. To bring awareness about prevention, management, and treatment of blood lipid disorders, the Government is promoting a healthy diet and physical activity participation, early detection and management of blood lipid disorders as well as update and review of drug lists and clinical protocols regularly to ensure impartial access to drugs and therapies of proven safety and efficacy. The overall scenario is predicted to make healthy growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Lipid Disorder Treatment.
The entire Lipid Disorder Treatment market has been sub-categorized into drug type, distribution channel, and indication. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Drug Type
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Familial Combined Hyperlipidemia
- Familial Defective Apolipoprotein B-100
- Familial Dysbetalipoproteinemia
- Familial Hypertriglyceridemia
- Heterozygous Familial Hypercholesterolemia
This section covers regional segmentation which accentuates on current and future demand for Lipid Disorder Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Lipid Disorder Treatment Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Lipid Disorder Treatment market include Pfizer, Inc, Novartis AG, Astrazeneca Plc, Merck and Co., Emcure Pharmaceuticals Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.